Categories AlphaGraphs, Earnings, Health Care
AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues decreased by 4%.
Net loss, excluding special items, was $0.08 per share in the February quarter, compared to a loss of $0.16 per share in the corresponding period of 2024. On an unadjusted basis, net loss narrowed to $4.41 million or $0.11 per share in Q2 from $187.7 million or $4.67 per share in the prior-year quarter.
Revenues, on a reported basis, decreased 4% year-over-year to $72.0 million in the third quarter. The company expects fiscal 2025 sales to be in the range of $285 million to $288 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “Based on the quality of performance
we have seen through fiscal 2025, we are increasing our fiscal full-year guidance for all of our key metrics, including; total worldwide revenue, MedTech revenue growth, gross margin, adjusted EBITDA, and adjusted EPS.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Pfizer’s (PFE) Q1 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to $2.96 billion, or $0.52 per
PYPL Earnings: PayPal reports higher Q1 2025 revenue and profit
PayPal Holdings Inc. (NASDAQ: PYPL) on Tuesday reported a modest increase in revenue for the first quarter of 2025 when the payment service giant's adjusted earnings rose by double digits.
General Motors (GM) Q1 2025 revenue and adj. earnings beat estimates
Auto giant General Motors (NYSE: GM) on Tuesday announced financial results for the first quarter of 2025, reporting an increase in revenue and adjusted profit. The results also topped expectations.
